```html

Hyperlipidemia (High Cholesterol): A Complete Patient Guide

Overview

Hyperlipidemia—often referred to as high cholesterol—is a metabolic condition characterized by elevated levels of lipids (fats) in the blood, primarily low‑density lipoprotein cholesterol (LDL‑C), total cholesterol, and triglycerides. While it can affect anyone, it is most common in adults over 40, though genetics can cause severe elevations in children and young adults.

According to the U.S. Centers for Disease Control and Prevention (CDC), about 38 % of American adults have “high” total cholesterol (≥240 mg/dL) and roughly 30 % have elevated LDL‑C. Worldwide, the World Health Organization (WHO) estimates that dyslipidemia contributes to 2.6 million deaths each year, largely through cardiovascular disease (CVD).

Hyperlipidemia is a major, modifiable risk factor for heart attack, stroke, and peripheral artery disease. Early detection and management can dramatically reduce these risks.

Symptoms

High cholesterol itself does not usually cause noticeable symptoms. This “silent” nature is why routine screening is essential. In rare, severe cases (familial hypercholesterolemia), patients may develop physical signs:

• Xanthomas: Yellowish cholesterol deposits under the skin, often on elbows, knees, or tendons.
• Arcus corneae: A white or gray ring around the outer edge of the cornea, more common in people under 50 with very high LDL‑C.
• Premature cardiovascular events: Chest pain (angina), shortness of breath, or heart attack before age 55 in men or 65 in women may be the first clue.

Because most people feel fine, a blood test—called a lipid panel—is the only reliable way to know your levels.

Causes and Risk Factors

Primary (Genetic) Causes

• Familial hypercholesterolemia (FH): An autosomal dominant disorder affecting ~1 in 250 people globally. Mutations in the LDLR, APOB, or PCSK9 genes impair the liver’s ability to remove LDL from the blood.
• Other inherited lipid disorders: Familial combined hyperlipidemia, hypertriglyceridemia, and rare metabolic diseases.

Secondary (Acquired) Causes

• Diet high in saturated fats, trans fats, and cholesterol (e.g., red meat, fried foods, commercial baked goods).
• Obesity and metabolic syndrome.
• Physical inactivity.
• Smoking.
• Excessive alcohol intake (especially >2 drinks/day for men, >1 for women).
• Medical conditions: diabetes mellitus, hypothyroidism, chronic kidney disease, liver disease, and polycystic ovary syndrome.
• Certain medications: glucocorticoids, some antiretrovirals, thiazide diuretics, and progestin‑only contraceptives.

Who Is at Higher Risk?

• Men over 45 and women over 55 (or post‑menopause).
• Family history of premature heart disease or high cholesterol.
• People with diabetes, hypertension, or a history of smoking.
• Individuals with a body mass index (BMI) ≥30 kg/m².
• Certain ethnic groups—e.g., South Asians, African Americans, and Pacific Islanders—have higher prevalence of dyslipidemia.

Diagnosis

The cornerstone of diagnosis is the fasting lipid panel, which measures:

• Total cholesterol
• Low‑density lipoprotein cholesterol (LDL‑C)
• High‑density lipoprotein cholesterol (HDL‑C)
• Triglycerides

Guidelines from the American College of Cardiology/American Heart Association (ACC/AHA) recommend:

• Screening adults age 20‑79 every 4‑6 years.
• Earlier and more frequent testing for those with risk factors (e.g., FH, diabetes, or strong family history).

Additional Tests When Indicated

• Non‑fasting lipid panel: Acceptable for most routine checks, especially for triglycerides <150 mg/dL.
• Lipoprotein(a) [Lp(a)]: Elevated Lp(a) is an independent risk factor for atherosclerosis.
• Apolipoprotein B (ApoB): Direct measurement of atherogenic particles.
• Advanced imaging: Coronary artery calcium scoring (CT) or carotid intima‑media thickness (ultrasound) to assess existing plaque when risk assessment is uncertain.

Treatment Options

Treatment aims to lower atherogenic lipids, raise protective HDL‑C, and reduce overall cardiovascular risk. Management is individualized based on age, risk profile, and the presence of comorbidities.

1. Lifestyle Modifications (First‑Line for All)

• Diet: Emphasize the Mediterranean or DASH patterns—plenty of fruits, vegetables, whole grains, legumes, nuts, fatty fish, and olive oil. Limit saturated fats (<7 % of calories), trans fats, and added sugars.
• Physical activity: At least 150 minutes/week of moderate‑intensity aerobic exercise (e.g., brisk walking) plus muscle‑strengthening activities twice weekly.
• Weight management: 5‑10 % weight loss can lower LDL‑C by ~5‑10 mg/dL and triglycerides by 10‑20 %.
• Smoking cessation: Improves HDL‑C and overall cardiovascular health.
• Alcohol moderation: No more than 2 drinks/day for men, 1 for women.

2. Pharmacologic Therapy

Medication decisions follow risk‑based algorithms (ACC/AHA 2018). Common classes include:

Statins (HMG‑CoA reductase inhibitors)

• First‑line for most patients; reduce LDL‑C by 20‑60 %.
• Examples: Atorvastatin, Rosuvastatin, Simvastatin.
• Side effects: Myalgia, rare rhabdomyolysis, modest increase in liver enzymes.

Ezetimibe

• Blocks intestinal cholesterol absorption; adds ~15‑20 % LDL‑C reduction when combined with a statin.

PCSK9 Inhibitors (monoclonal antibodies)

• Alirocumab, Evolocumab – injectable agents that can lower LDL‑C by up to 60 %.
• Indicated for FH, statin‑intolerant patients, or those who need additional reduction.

Bile‑Acid Sequestrants

• Cholestyramine, Colesevelam – lower LDL‑C by 15‑30 %.
• Can cause GI upset and interfere with absorption of other medications.

Niacin (Vitamin B3)

• Raises HDL‑C and lowers triglycerides, but limited use due to flushing and liver toxicity.

Fibrates

• Gemfibrozil, Fenofibrate – primarily lower triglycerides and modestly raise HDL‑C.
• Best for isolated hypertriglyceridemia (>200 mg/dL).

Omega‑3 Fatty Acid Supplements

• Prescription EPA/DHA formulations (e.g., icosapent ethyl) can lower triglycerides by 30‑50 % and have shown cardiovascular benefit.

3. Procedural Options

• Lipid‑Apheresis: Mechanical removal of LDL‑C from blood; reserved for patients with severe FH who fail maximal medical therapy.
• Coronary revascularization (angioplasty, bypass): Not a treatment for hyperlipidemia per se, but may be required when atherosclerotic disease has already caused blockages.

Living with Hyperlipidemia (high cholesterol)

Successful long‑term control hinges on everyday choices and regular follow‑up.

Practical Daily Tips

• Meal planning: Use the "plate method" – half vegetables, quarter lean protein, quarter whole grains; add a small portion of healthy fats (olive oil, avocado).
• Read labels: Look for 0 g trans fat and ≤5 g saturated fat per serving.
• Physical activity consistency: Set a daily step goal (e.g., 10,000 steps) or schedule three 30‑minute walks.
• Medication adherence: Use a weekly pill organizer or set phone reminders.
• Regular monitoring: Repeat lipid panels every 3‑12 months as directed; track results in a health journal.
• Family screening: First‑degree relatives should have lipid testing, especially if FH is suspected.

Emotional & Social Support

Living with a chronic condition can be stressful. Consider:

• Joining a cholesterol‑focused support group (online forums, local community groups).
• Working with a registered dietitian for personalized meal plans.
• Discussing concerns with your clinician—especially side effects or medication costs.

Prevention

Even if you have normal cholesterol today, preventive measures lower the chance of future dyslipidemia.

• Adopt heart‑healthy eating early: Mediterranean diet patterns can be started in childhood.
• Maintain a healthy weight: Every kilogram lost can reduce LDL‑C by 1‑2 mg/dL.
• Stay active: Even light‑to‑moderate activity (e.g., gardening) improves lipid profiles.
• Control blood pressure & blood sugar: Hypertension and diabetes accelerate atherosclerosis.
• Screen regularly: Begin cholesterol testing at age 20 for men and 45 for women, or earlier if risk factors exist.
• Vaccinations: Flu and COVID‑19 vaccines reduce systemic inflammation that can worsen lipid levels.

Complications

If left untreated, high cholesterol accelerates the formation of atherosclerotic plaques, leading to:

• Coronary artery disease (CAD): Chest pain, myocardial infarction, heart failure.
• Ischemic stroke: Plaque rupture or emboli from carotid arteries.
• Peripheral artery disease (PAD): Leg pain, non‑healing wounds, risk of amputation.
• Aortic aneurysm: Weakened arterial wall can enlarge and rupture.
• Pancreatitis: Very high triglycerides (>1,000 mg/dL) can trigger acute pancreatitis.

These events are leading causes of morbidity and mortality worldwide. Early lipid‑lowering therapy can cut the risk of major cardiovascular events by up to 30 % (see Mayo Clinic).

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, NIH National Heart, Lung, & Blood Institute, American Heart Association, ACC/AHA Guideline (2018), WHO Global Health Estimates, Cleveland Clinic.

```